NCT03216889

Brief Summary

The purpose of this study is to learn if cognitive behavioral therapy for insomnia (CBT-I) will improve sleep quality, fatigue, and quality of life in individuals with multiple sclerosis (MS) with symptoms of insomnia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 29, 2017

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 11, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 13, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2019

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

2.1 years

First QC Date

July 11, 2017

Last Update Submit

August 26, 2019

Conditions

Keywords

Multiple Sclerosis

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity Index (ISI)

    The ISI consists of 7 questions, each rated on a 0-4 scale. The range of scores on the ISI is 0-28, with a score of ≥ 10 suggesting clinical insomnia. The lower the score the less severe insomnia.

    Change from Baseline to Week 7

Secondary Outcomes (4)

  • Pittsburgh Sleep Quality Index (PSQI)

    Change from Baseline to Week 7

  • Modified Fatigue Impact Scale (MFIS)

    Change from Baseline to Week 7

  • Fatigue Severity Scale (FSS)

    Change from Baseline to Week 7

  • Multiple Sclerosis Impact Scale (MSIS)

    Change from Baseline to Week 7

Study Arms (2)

Cognitive Behavioral Therapy for Insomnia (CBT-I)

EXPERIMENTAL

6 weeks of CBT-I.

Behavioral: Cognitive Behavioral Therapy for Insomnia

Control

ACTIVE COMPARATOR

6 weeks of stretching and thinking games.

Behavioral: Control

Interventions

Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will be one-on-one or in a group.

Cognitive Behavioral Therapy for Insomnia (CBT-I)
ControlBEHAVIORAL

Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will involve stretching and thinking games.

Control

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of MS by physician
  • Report of difficulty falling asleep, maintaining sleep, or waking up too early at least 3 nights/week for the past 6 months,
  • ≥10 on Insomnia Severity Index
  • English speaking
  • Core at least 24 on the Mini-Mental State Exam (MMSE) to indicate reduced risk of dementia

You may not qualify if:

  • Known untreated sleep disorder (such as sleep apnea or restless leg syndrome)
  • \>4 on STOP BANG indicating high risk of sleep apnea
  • Increased risk of restless leg syndrome on Restless Legs Syndrome (RLS) Diagnosis Index
  • Nervous system disorder other than MS
  • Relapse and/or corticosteroid use in past 8 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersMultiple Sclerosis

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Katie Siengsukon, PT, PhD

    University of Kansas Medical Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2017

First Posted

July 13, 2017

Study Start

June 29, 2017

Primary Completion

August 15, 2019

Study Completion

August 15, 2019

Last Updated

August 28, 2019

Record last verified: 2019-08

Locations